Evidence map›Paper›PMID 30903349›Full record

ArticleParasitology research2019

In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.

Julio Alberto Rojas Vargas, América García López, Yulier Pérez, Paul Cos, Matheus Froeyen

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Econazole Exhibits In Vitro and In Vivo Efficacy AgainstPharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Article
  4. InhibitingPharmaceuticals (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julio Alberto Rojas VargasChemistry Department, Exact and Natural Science Faculty, Oriente University, Santiago de Cuba, Cuba. jarojas@uo.edu.cu.
América García LópezChemistry Department, Exact and Natural Science Faculty, Oriente University, Santiago de Cuba, Cuba.
Yulier PérezChemistry Department, Exact and Natural Science Faculty, Oriente University, Santiago de Cuba, Cuba.
Paul CosLaboratory of Microbiology, Parasitology and Hygiene (LMPH), S7, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Wilrijk, Belgium.
Matheus FroeyenMedicinal Chemistry, Department of Pharmacy, Rega Institute, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-8675-6540

Funding

VLIR-UOS (Vlaanderen) IUC programme with Universidad de Oriente, Santiago de Cuba,
6 · The paper itself

Abstract

There is an urgent need to discover and develop new drugs to combat parasitic diseases as Chagas disease (Trypanosoma cruzi), sleeping sickness (Trypanosoma brucei), and leishmaniasis (Leishmania ssp.). These diseases are considered among the 13 most unattended diseases worldwide according to the WHO. In the present work, the synthesis of 14 arylsubstituted imidazoles and its molecular docking onto sterol 14α-demethylase (CYP51) was executed. In addition, the compounds, antiprotozoal activity against T. brucei, T. cruzi, Trypanosoma brucei rhodesiense, and Leishmania infantum was evaluated. In vitro antiparasitic results of the arylsubstituted imidazoles against T. brucei, T. cruzi, T.b. rhodesiense, and L. infantum indicated that all samples from arylsubstituted imidazole compounds presented interesting antiparasitic activity to various extent. The ligands 5a, 5c, 5e, 5f, 5g, 5i, and 5j exhibited strong activity against T. brucei, T. cruzi, T.b. rhodesiense, and L. infantum with IC

Indexed as

AnimalsAntiprotozoal AgentsCell LineChagas DiseaseHumansImidazolesLeishmania infantumLeishmaniasisMolecular Docking SimulationSterol 14-DemethylaseTrypanosoma brucei bruceiTrypanosoma cruziTrypanosomiasis, AfricanAntiprotozoal AgentsImidazolesSterol 14-DemethylaseArylsusbtituted imidazolesIn vitro evaluationLeishmania infantumMolecular dockingTrypanosoma b. rhodesienseTrypanosoma bruceiTrypanosoma cruzi

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.